Clinical Trial Update: Comparative Effect of Nigella Sativa and Conventional Management for OSMF [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Nigella Sativa with conventional management for Oral Submucous Fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Submucous Fibrosis

Drugs mentioned

• Nigella Sativa (Nigella sativa)

Snippet

Sponsor: Ziauddin University | Conditions: Oral Submucous Fibrosis | Phase 3 | Status: COMPLETED